Establishment Labs Holdings (ESTA) Income from Continuing Operations (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Income from Continuing Operations of 13382000.0 in Q1 2026, down 411.74% quarter-over-quarter from 2615000.0 in Q4 2025, and up 35.38% on a YoY basis from 9884486.05 in Q1 2025.
Establishment Labs Holdings (ESTA) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 13382000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 35.38% year-over-year to 13382000.0; the TTM figure through Mar 2026 stood at 43736000.0 (up 50.92% YoY), while the FY2025 annual figure was 51064000.0, up 39.64% from the prior year.
- Income from Continuing Operations was 13382000.0 for Q1 2026 at Establishment Labs Holdings, down from 2615000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 2615000.0 in Q4 2025 to a low of 37106000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 17809000.0 across 5 years, with a median of 16682000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 597.22% in 2022, then jumped 92.43% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 13562000.0 in 2022, then slumped by 51.47% to 20542000.0 in 2023, then tumbled by 68.1% to 34531000.0 in 2024, then surged by 92.43% to 2615000.0 in 2025, then sank by 411.74% to 13382000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 13382000.0 (Q1 2026), 2615000.0 (Q4 2025), and 11146000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | -13.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.38 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Sep 30, 2025 | -11.15 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | -34.53 Mn |
| Sep 30, 2024 | -16.68 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Mar 31, 2024 | -16.20 Mn |
| Dec 31, 2023 | -20.54 Mn |
| Sep 30, 2023 | -29.27 Mn |
| Jun 30, 2023 | -16.75 Mn |
| Mar 31, 2023 | -11.94 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -18.61 Mn |
| Jun 30, 2022 | -37.11 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -14.19 Mn |
| Sep 30, 2021 | -14.68 Mn |
| Jun 30, 2021 | -5.32 Mn |